Polynovo Share Price and Company Fundamentals



Price
$0.945
Change
-0.010 (-1.047%)
52 week range
0.81 - 1.66

Last traded: Today at 6:10 AM

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Key Metrics

PE ratio

94.50

PB ratio

7.21

Dividend yield

-

Beta

1.36

Market cap

$652.85M

Enterprise value

$641.89M

Company profile

Industry / Sector Medical Devices / Healthcare
Website https://polynovo.com
Mailing address 320 Lorimer Street Unit 2 Port Melbourne VIC 3207 Australia
Phone / Fax 61 3 8681 4050 / 61 3 8681 4099

Dividends

More: Polynovo Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Polynovo paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PNV dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Sep 2026, following are the company executives and directors listed on Polynovo.

Name Title Age Total Pay
Mr. Jan-Marcel Gielen C.A. CFO & Company Secretary
Dr. Marthe D'Ombrain Chief Scientific Officer
Ms. Amy Demediuk Company Secretary & General Counsel
Ms. Kimberley Axon Chief People Officer
Mr. Edward Graubart President of North America

Profitability and management effectiveness

Profit margin

4.90%

Operating margin

14.10%

Return on assets

6.42%

Return on equity

8.44%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Polynovo is 652.85M and its enterprise value is 641.89M. The enterprise value to revenue ratio of PNV is 4.28. The enterprise value to EBITDA ratio of PNV is 41.51.

The PNV's stocks Beta value is 1.36 making it 36% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Polynovo (PNV)

Polynovo (ASX:PNV) Frequently Asked Questions

1. What is Polynovo's Stock Symbol?

Polynovo trades on ASX under the ticker symbol "PNV".

2. What is Polynovo's stock price today?

One share of PNV stock can currently be purchased for approximately $0.945.

3. How can I contact Polynovo?

Polynovo's mailing address is 320 Lorimer Street Unit 2 Port Melbourne VIC 3207 Australia. The company can be reached via phone at 61 3 8681 4050.

4. What is Polynovo's official website?

The official website of Polynovo is https://polynovo.com.